biotech · Major Depressive Disorder · Schizophrenia · NBIX
NEUROCRINE BIOSCIENCES
NEUROCRINE BIOSCIENCES INC
NEUROCRINE BIOSCIENCES clinical programs — 28 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 6027 Edgewood Bend Ct, San Diego, California 92130, US
- Founded
- 1992
- Employees
- 2,307
- Programs
- 79
- Drugs
- 28
- Patents
- 111
NEUROCRINE BIOSCIENCES projects
28 ClinicalTrials.gov programs sponsored by NEUROCRINE BIOSCIENCES.
NEUROCRINE BIOSCIENCES has 28 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Amphetamine
NEUROCRINE BIOSCIENCES INC
Healthy Volunteers
1 trial -
Chronocort
NEUROCRINE BIOSCIENCES INC
Adrenal Insufficiency
2 trials -
DITEST
NEUROCRINE BIOSCIENCES INC
Male Hypogonadism
1 trial -
Dexamethasone
NEUROCRINE BIOSCIENCES INC
Healthy
1 trial -
Effect of NBI-921355 on corticospinal excitability in healthy participants
NEUROCRINE BIOSCIENCES INC
Epilepsy
1 trial -
Elagolix
NEUROCRINE BIOSCIENCES INC
Folliculogenesis
1 trial -
Hydrocortisone granules
NEUROCRINE BIOSCIENCES INC
Adrenal Insufficiency
1 trial -
Infacort
NEUROCRINE BIOSCIENCES INC
Healthy Subjects
1 trial -
NBI-1076986-1761
NEUROCRINE BIOSCIENCES INC
Movement disorders
1 trial -
NBI-1117570-1769
NEUROCRINE BIOSCIENCES INC
Neurological and neuropsychiatric conditions
1 trial -
NBI-6024
NEUROCRINE BIOSCIENCES INC
Type 1 Diabetes Mellitus
1 trial -
NBI-77860
NEUROCRINE BIOSCIENCES INC
Congenital Adrenal Hyperplasia
1 trial -
NBI-98854 50 mg capsule
NEUROCRINE BIOSCIENCES INC
Safety, Tolerability, and PK of NBI-98854 in Hepatically Impaired Subjects
1 trial -
NBI-98854 50 mg capsule once daily
NEUROCRINE BIOSCIENCES INC
Effect of Ketoconazole on the PK of NBI-98854 in Healthy Subjects
1 trial -
Opicapone
NEUROCRINE BIOSCIENCES INC
Parkinson Disease
1 trial -
TAK-041
NEUROCRINE BIOSCIENCES INC
Healthy Volunteers
1 trial -
TAK-653
NEUROCRINE BIOSCIENCES INC
Healthy Volunteers
1 trial -
TAK-653 Placebo
NEUROCRINE BIOSCIENCES INC
Depressive Disorder
1 trial -
TAK-831
NEUROCRINE BIOSCIENCES INC
Healthy Volunteers
2 trials -
TAK-831
NEUROCRINE BIOSCIENCES INC
Healthy
1 trial -
TAK-831 Oral Suspension
NEUROCRINE BIOSCIENCES INC
Schizophrenia, Cerebellar Ataxia
1 trial -
TAK-831 Oral Tablet
NEUROCRINE BIOSCIENCES INC
Healthy Volunteers
1 trial -
TAK-831 T2
NEUROCRINE BIOSCIENCES INC
Healthy Volunteers
1 trial -
TAK-831 Tablet T2
NEUROCRINE BIOSCIENCES INC
Healthy
1 trial -
VY-AADC01
NEUROCRINE BIOSCIENCES INC
Parkinson's Disease
1 trial -
VY-AADC01
NEUROCRINE BIOSCIENCES INC
Idiopathic Parkinson's Disease
1 trial -
VY-AADC02
NEUROCRINE BIOSCIENCES INC
Parkinson's Disease
1 trial -
interleukin-4 PE38KDEL cytotoxin
NEUROCRINE BIOSCIENCES INC
Breast Cancer
1 trial
Frequently asked questions
How many clinical projects does NEUROCRINE BIOSCIENCES have?
28 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.